StonvexLoading…
StonvexStonvexStonvexCore line items from CUE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $27.47M | $9.29M | $5.49M | $1.25M |
Operating Income | $-26.55M | $-41.50M | $-52.15M | $-53.23M |
Net Income | $-26.60M | $-40.67M | $-50.73M | $-53.01M |
EPS (Diluted) | $-0.28 | $-0.72 | $-1.11 | $-1.49 |
Total Assets | $42.21M | $32.19M | $61.53M | $91.28M |
Total Liabilities | $15.78M | $14.69M | $24.45M | $25.60M |
Cash & Equivalents | $27.14M | $22.46M | $48.51M | $51.61M |
Free Cash Flow OCF − CapEx | $-21.86M | $-36.40M | $-39.96M | $-41.98M |
Shares Outstanding | 96.62M | 61.82M | 47.22M | 47.22M |